Biodiversity
OtherIn rewilding kindergartens, the yards are modified with biological elements, i.e., vegetation and plantation will be added to the yards.
NCT Number: NCT06390878
Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities that is associated with altered commensal microbiota and a rising burden of immunological disorders among urban children.
The investigators will estimate how rewilding of kindergarten yards affects commensal microbiome, prevalence of allergies, asthma, atopic dermatitis and infections, cortisol levels, cognitive skills and plasma cytokine levels of children.
Our specific aims are:
To assess if rewilding diversifies health-associated skin, saliva and gut microbiota and reduces infectious diseases and atopic or allergic symptoms.
Assess whether the rewilding has positive effects on cognitive skills. Assess whether the rewilding changes cortisol and plasma cytokine levels. The investigators will recruit altogether 320 (160 per treatment) study subjects aged between 1-5 to questionnaire study (Task 2), from which 120 study subjects will be analyzed more detailed using microbiological and blood samples (Task 1).
Interested in participating?
Request Info1 year–5 year
All sexes
Interventional
Not applicable
Natural Resources Institute Finland, Helsinki, Uusimaa, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In rewilding kindergartens, the yards are modified with biological elements, i.e., vegetation and plantation will be added to the yards.
Playground equipment that increase the physical activity of children will be added to the kindergarten yards.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Difference on skin gammaproteobacterial diversity between rewilding and control group
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Cortisol levels measured from hair samples
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if microbial communities are different between treatments
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Higher score in observed species richness of commensal microbiota among biodiversity treatment
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if microbial communities are different between treatments
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if the distribution is different between treatments
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
White blood cell transcriptome is analyzed with single cell RNA sequencing.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Cytokines will be analyzed analyzed with Meso Scale.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Cytokines will be analyzed using skin tape strip samples.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Infections will be recorded with questionnaires.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Asthma symptoms will be recorded with questionnaires.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Atopic dermatitis will be recorded with questionnaires.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Allergies will be recorded with questionnaires.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Lower score on patient-oriented Eczema Measure among intervention treatment compared to control that indicates lower eczema among intervention treatment. Minimum 0, maximum 28.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
Higher score on Wechsler Preschool and Primary Scale of Intelligence among intervention treatment compared to control that indicates better cognitive skills among intervention treatment. Minimum 40, maximum 170.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with cytokine levels.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with richness of commensal microbiota.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with white blood cell distributions.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with cortisol levels.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with cognitive skills.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with the prevalence of infectious diseases.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with the atopic dermatitis
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with the allergy symptoms.
Time frame: Baseline, 3 month, 1 year, 2 year, 3 year
It will be analyzed if environmental factors correlate with the asthma symptoms.
Contact information is provided by the study sponsor or research team.
Natural Resources Institute Finland
Other Gov
Nationwide Research on the Rewilding of Kindergarten Yards - Vahvistu
Acronym: Vahvistu
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05934422
Allergy, Atopic Dermatitis
Auckland, New Zealand
View Trial DetailsNCT06390696
Atopic Dermatitis, Communicable Diseases
Helsinki, Uusimaa, Finland
View Trial DetailsNCT06248983
Communicable Diseases, Disease Attributes
Hoofddorp, North Holland, Netherlands
View Trial DetailsNCT06390683
Autism Spectrum Disorder, Behavior
Helsinki, Uusimaa, Finland
View Trial Details